Eric J. Hyllengren, EVP, CFO at Atara Biotherapeutics, Inc. (ATRA), sold 28,648 shares at $0.62 ($18K) on 2024-05-16, disclosed to the SEC on 2024-05-20.
Open-market sale of $18k ATRA by EVP, CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ATRA | SELL | 2024-08-20 | $7K | — | Filing → |
| ATRA | SELL | 2024-03-06 | $5K | — | Filing → |
| ATRA | SELL | 2023-11-20 | $5K | — | Filing → |